Plasma assay of methadone enantiomers with high performance liquid chromatography;Dosage plasmatique des énantiomères de la méthadone par chromatographie liquide à haute performance

Annales Pharmaceutiques Francaises

Volumn 62, Issue 3, 2004, Pages 193-200

  Batista, R ^a   Badre Sentenac S ^a   Bardin, C ^a   Chast, F ^a  

^a HÔTEL DIEU   (France)

Author keywords

High Performance Liquid Chromatography; Methadone; Pharmacokinetics; Stereochemistry

Indexed keywords

DEXTROPROPOXYPHENE; METHADONE; OPIATE;

ANALGESIC ACTIVITY; ANALYTIC METHOD; ARTICLE; CHIRAL CHROMATOGRAPHY; DRUG DETERMINATION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STEREOSPECIFICITY; ULTRAVIOLET RADIATION;

EID: 3042784897     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0003-4509(04)94302-7     Document Type: Article

References (17)

1. Payte JT. A brief history of methadone in the treatment of opioid dependence: a personal perspective, J Psychoactive Drugs 1991; 23 (2): 103-7.
2. Anonyme, Circulaire DGS/DH n° 096/239 du 3 avril 1996 relative aux orientations dans le domaine de la prise en charge des toxicomanes en 1996. MTAS/MTAVI 96/ 16: 105-24.
3. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine, Life Sci 1995; 56 (2): 45-50.
4. Kristensen K, T Blemmer, HR Angello, LL Christrup, NE Drenck, SN Rasmussen, P Sjogren. Stereoselective pharmacokinetics of methadone in chronic pain patients, Ther Drug Monitor 1996; 18: 221-7.
5. Wolff K, A Rostami-Hodjegan, S Shires, AW Hay, M Feely, R Calvert, D Raistrick, GT Tucker. The pharmacokinetics of methadone in healthy subjects and opiate users, Br J Clin Pharmacol 1997; 44 (4): 325-34.
6. Mercadante S, M Sapio, R Serretta, M Caligara. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report. Ann Oncol 1996 Aug; 7 (6): 613-7.
7. Rudaz S, JL Veuthey. Chiral stationary phases in HPLC for the stereoselective determination of methadone, J Pharm Biomed Anal 1996; 14: 1271-9.
8. Ufkes JG, JW De Vos, GH Van Brussel. Determination and pharmacokinetics of dextromoramide in methadone maintenance therapy, Pharm World Sci 1998; 20 (2): 83-7.
9. Pradeau D. Analyse pratique du médicament. (1992) Éditions Médicales Internationales, Cachan, France.
10. Schmidt N, K Brune, G Geissliner. Stereoselective determination of the enantiomers of methadone in plasma using high-performance liquid chromatography, J Chromatogr 1992; 583: 195-200.
11. American Society of Health-System Pharmacists. AHFS Drug Information 1995: 1392.
12. Norris RL, PJ Ravenscroft, SM Pond. Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma, J Chromatogr B 1994; 661: 346-50.
13. Beck O, LO Boreus, P Lafolie, G Jacobsson. Chiral analysis of methadone in plasma by high-performance liquid chromatography, J Chromatogr Biomed Appl 1991; 570, 1: 198-202.
14. Kell MJ. Utilization of plasma and urine methadone concentration measurements to limit narcotics use in methadone maintenance patients: II. Generation of plasma concentration response curves. J Addict Dis 1995; 14 (1): 85-108.
15. De Vos JW, PJ Geerlings, W Van Den Brink, JG Ufkes, H Van Wilgenburg. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts, Eur J Clin Pharmacol 1995; 48 (5): 361-6.
16. Wolff K, M Sanderson M, AW Hay, D Raistrick. Methadone concentrations in plasma and their relationship to drug dosage, Clin Chem 1991 Feb; 37 (2): 205-9.
17. Repetto MR, M Repetto. Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans, Clin Toxicol 1997; 35: 1-9.